Efficacy of doxycycline release collagen membrane on surgically created and contaminated defects in rat tibiae: A

Esma Kütan1, Gonca Duygu-Çapar2, Ceyda Özçakir-Tomruk3

  • 1Department of Oral Implantology, Faculty of Dentistry, Yeditepe University,Göztepe, Istanbul, Turkey.

Archives of Oral Biology
|December 15, 2015
PubMed
Abstract

Insights

A doxycycline-releasing collagen membrane enhanced bone formation and prevented infection in guided bone regeneration (GBR) procedures. This localized antibiotic delivery offers a promising solution for contaminated GBR defects, promoting better osteogenesis.

Area of Science:

  • Biomaterials Science
  • Regenerative Medicine
  • Periodontology

Background:

  • Systemic antibiotics have limited efficacy in controlling pathogens during guided bone regeneration (GBR), particularly with membrane exposure.
  • Local antibiotic delivery in GBR is an underutilized approach.

Purpose of the Study:

  • To evaluate the osteogenesis potential and antibacterial efficacy of a doxycycline-releasing collagen membrane.
  • To assess its impact on surgically created and contaminated defects in a rat tibia model.

Main Methods:

  • Surgically created defects in 20 rats were contaminated with Porphyromonas gingivalis.
  • Defects were grafted and covered with either a standard collagen membrane (control) or a doxycycline-releasing collagen membrane (test group).
  • Microbiologic and histopathological evaluations were performed on days 14 and 28, respectively.

Main Results:

  • The doxycycline-releasing membrane group demonstrated significantly higher osteogenesis compared to the control group (p=0.011).
  • No bacterial growth was detected in the test group.
  • Bacterial counts in the control group ranged from 1x10^4 to 268x10^4 CFU/g.

Conclusions:

  • Doxycycline-releasing membranes positively impact contaminated GBR procedures by limiting P. gingivalis infections.
  • This localized delivery promotes bone formation in GBR, as evidenced in a rat model.
  • The findings suggest a potential benefit for doxycycline-releasing membranes in managing GBR complications.

Related Concept Videos